Literature DB >> 18515556

Risk factors for death among tuberculosis cases: analysis of European surveillance data.

N Lefebvre1, D Falzon.   

Abstract

The proportion of tuberculosis (TB) patients in the European Union (EU) who die remains high (8% overall). The aim of the present study was to quantify the risk of dying associated with demographic and clinical factors. Case-based data on 39,566 TB patients notified by 15 EU countries during 2002-2004 were analysed using logistic regression. It was observed that advancing age and resistance to isoniazid and rifampicin were the strongest determinants of death, while male sex, European origin, pulmonary site of disease and previous anti-TB treatment were weaker predictors. Risk varied between reporting countries, presumably reflecting differences in patient profiles, reporting practices and programme effectiveness. In conclusion, earlier suspicion, diagnosis and treatment may reduce deaths, particularly among the elderly. Special attention is needed to avert the development and transmission of multidrug-resistant tuberculosis.

Entities:  

Mesh:

Year:  2008        PMID: 18515556     DOI: 10.1183/09031936.00131107

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  32 in total

1.  A retrospective case-control study, factors affecting treatment outcomes for pulmonary tuberculosis in istanbul, Turkey.

Authors:  Aylin Babalık; Zeki Kılıçaslan; Sule Kızıltaş; Serap Gencer; Gül Ongen
Journal:  Balkan Med J       Date:  2013-06-01       Impact factor: 2.021

2.  Association of Xpert MTB/RIF Cycle Threshold Values with Tuberculosis Treatment Outcomes.

Authors:  Matheus de Matto Pires; Giovana Rodrigues Pereira; Márcia Silva Barbosa; Natan José Dutra Dias; Carina Secchi; Jociane Saldanha Hoff; Denise Rossato Silva
Journal:  Lung       Date:  2020-10-31       Impact factor: 2.584

Review 3.  [Pulmonary and pleural tuberculosis in the elderly].

Authors:  Gerhard Hoheisel; Anne Hagert-Winkler; Jörg Winkler; Thomas Kahn; Arne C Rodloff; Hubert Wirtz; Adrian Gillissen
Journal:  Med Klin (Munich)       Date:  2009-10-25

4.  A mortality review of adult inpatients with tuberculosis in Mendi, Papua New Guinea.

Authors:  K Vakadem; A Anota; M Sa'avu; C Ramoni; L Comrie-Thomson; M Gale; R J Commons
Journal:  Public Health Action       Date:  2019-09-21

5.  Neutrophilia independently predicts death in tuberculosis.

Authors:  David M Lowe; Asela K Bandara; Geoffrey E Packe; Richard D Barker; Robert J Wilkinson; Christopher J Griffiths; Adrian R Martineau
Journal:  Eur Respir J       Date:  2013-10-10       Impact factor: 16.671

6.  Time of highest tuberculosis death risk and associated factors: an observation of 12 years in Northern Thailand.

Authors:  Saiyud Moolphate; Myo Nyein Aung; Oranuch Nampaisan; Supalert Nedsuwan; Pacharee Kantipong; Narin Suriyon; Chamnarn Hansudewechakul; Hideki Yanai; Norio Yamada; Nobukatsu Ishikawa
Journal:  Int J Gen Med       Date:  2011-02-28

7.  Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis.

Authors:  Payam Nahid; Leah G Jarlsberg; Irina Rudoy; Bouke C de Jong; Alon Unger; L Masae Kawamura; Dennis H Osmond; Philip C Hopewell; Charles L Daley
Journal:  BMC Infect Dis       Date:  2011-01-03       Impact factor: 3.090

8.  Deaths among tuberculosis cases in Shanghai, China: who is at risk?

Authors:  Xin Shen; Kathryn Deriemer; Zheng'an Yuan; Mei Shen; Zhen Xia; Xiaohong Gui; Lili Wang; Jian Mei
Journal:  BMC Infect Dis       Date:  2009-06-17       Impact factor: 3.090

9.  Tuberculosis treatment adherence and fatality in Spain.

Authors:  Joan A Caylà; Teresa Rodrigo; Juan Ruiz-Manzano; José A Caminero; Rafael Vidal; José M García; Rafael Blanquer; Martí Casals
Journal:  Respir Res       Date:  2009-12-01

10.  Risk factors related with mortality in patient with pulmonary tuberculosis.

Authors:  Chong Whan Kim; Sang-Ha Kim; Shun Nyung Lee; Seok Jeong Lee; Myoung Kyu Lee; Ji-Ho Lee; Kye Chul Shin; Suk Joong Yong; Won Yeon Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.